Stephen Espitia

Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization

William Thomsen, Andrew J. Grottick, Frederique Menzaghi et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 401 citations

Discovery and Structure−Activity Relationship of (1<i>R</i>)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1<i>H</i>-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT_2C Receptor Agonist for the Treatment of Obesity

Brian M. Smith, Jeffrey M. Smith, James H. Tsai et al. · Journal of Medicinal Chemistry · 2007 · 200 citations · Full text

Subtype-Selective <i>N</i>-Methyl-<scp>d</scp>-Aspartate Receptor Antagonists:  Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines

Jonathan L. Wright, Tracy F. Gregory, Suzanne R. Kesten et al. · Journal of Medicinal Chemistry · 2000 · 110 citations

Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors

Jon E. Hawkinson, Manuel Acosta-Burruel, Stephen Espitia · European Journal of Pharmacology · 2000 · 47 citations

Opioid Epidemic, Health Sciences, Opioid Receptors +11

Structure−Activity Relationships of Alkyl- and Alkoxy-Substituted 1,4-Dihydroquinoxaline-2,3-diones:  Potent and Systemically Active Antagonists for the Glycine Site of the NMDA Receptor

Sui Xiong Cai, Sunil M. Kher, Zhang‐Lin Zhou et al. · Journal of Medicinal Chemistry · 1997 · 44 citations · Full text